CitoCBC™ Analyzer:
The first CLIA-Waived, cartridge-based CBC analyzer delivering full 5‑part differential in just 8 minutes.
What Is the CitoCBC™ Analyzer?
CitoCBC™ is a compact, desktop hematology system that provides a complete blood count with 5-part differential, delivering results equivalent to traditional laboratory analyzers. Its disposable cartridge (“Chip”) integrates microfluidics and reagents, enabling a simple, fast, and accurate test procedure with only a minimal sample volume.
With its small footprint and minimal maintenance requirements, and built-in support for LIS/EMR connectivity (HL7-standard), CitoCBC™ is designed for easy integration into any practice, helping medical professionals expand access to CBC testing without requiring specialized lab personnel or equipment.
Exclusive Partnership with Henry Schein
Henry Schein is the exclusive distributor of the CitoCBC™ Analyzer through a strategic partnership with CytoChip. This exclusive relationship ensures that healthcare providers have direct access to the latest cartridge-based hematology innovations. By partnering with CytoChip, Henry Schein delivers a breakthrough hematology solution that cannot be purchased through any other distributor, giving your practice unique access to the industry’s first CLIA-Waived, cartridge-based CBC system.
I want to learn moreTime is Critical in Clinical Decision-Making
The CitoCBC™ Analyzer delivers a complete CBC with 5-part differential in just 8 minutes, allowing healthcare providers to:
• Diagnose and monitor anemia, infections, and hematologic conditions during the same visit
• Reduce patient callbacks and follow-up visits
• Make immediate, informed treatment decisions
Its built-in internal quality control (IQC) ensures reliability with every test, while its CLIA-Waived status allows personnel with minimal training to perform testing confidently and safely.
Lab-Grade Accuracy in a Compact System
CitoCBC™ provides state-of-the-art performance that rivals hospital‑grade analyzers:
Substantially equivalent to leading lab analyzers
Performance validated to CLIA hematology allowable-error criteria, ensuring high analytical confidence in every result
Optical Fluorescent Platelet (OFP) technology enhances platelet discrimination and accuracy compared with traditional impedance-based systems
These features provide actionable, accurate data that medical professionals can trust for clinical decision making all without the cost, space, and training requirements of traditional hematology labs.
Low Maintenance, Easy to Use
CitoCBC™ is designed to reduce operational complexity:
• Disposable cartridge system eliminates reagent handling, calibration, and routine cleaning
• Room-temperature storage simplifies logistics
• Minimal training required any staff member can run tests efficiently
• Only a monthly QC check is needed to maintain compliance and accuracy
Flexible Sample Support
The analyzer supports multiple sample types:
• U.S. Venous whole blood collected in K₂EDTA vacutainers
• Europe (CE Mark) Venous or capillary whole blood anticoagulated with EDTA
• Regulatory clearance is being pursued for direct capillary blood testing, further expanding its usability in point-of-care settings
Benefits for Medical Professionals
CitoCBC™ provides tangible advantages for both clinicians and their practices:
-
Rapid turnaround: Complete blood count results in just 8 minutes, enabling same-visit clinical decisions
-
Ease of use: Minimal training and CLIA-Waived status allow staff at any skill level to perform tests
-
Reliable results: Lab-grade accuracy ensures confidence in diagnoses and treatment planning
-
Reduced costs: Eliminates the need for outsourcing CBC tests or investing in full laboratory analyzers
-
Enhanced patient care: Improves workflow, reduces delays, and increases patient satisfaction
CitoCBC™ is ideal for physician offices, urgent care centers, community clinics, nursing homes, pharmacies, and any healthcare setting where timely, accurate hematology testing can enhance patient outcomes.
